Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors

Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors - Prospective study of protoporphyrin IX fluorescence and spectral detection in digestive malignant tumors

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000023350

Enrollment

300

Registered

2016-07-27

Start date

2016-06-30

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

digestive malignant tumor

Interventions

2days

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Age of patients at start of the trial is 20 years or older 2) Patients with digestive malignant tumors with the need of pathological diagnosis before treatment

Exclusion criteria

Exclusion criteria: 1) Patients with porphyrinemia 2) Patients with hypersensitivity or a medical history with porphyrin related adverse events 3) People who have taken chemotheraphy for malignant tumors within one month before the start of the trial 4) Patients who have had other cancers 5) Patients who are taking anticoagulant or antithrombotic drugs 6) Women who are pregnant or are possibly pregnant 7) Patients with positive HBs antigen or HCV antibody

Design outcomes

Primary

Measure	Time frame
The detection rate for malignant tumors by using protoporphyrin IX fluorescence and endemism spectral detection	—

Countries

Japan

Contacts

Public ContactHiroki Kurumi

Department of Multidisciplinary Internal Medicine Faculty of Medicine,Tottori University Division of Medicine and Clinical Science

kurumi_1022_1107@yahoo.co.jp0859-38-6527

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026